$STTK SEC Filings

Filed On	Filing
27 Oct 2026	SCHEDULE 13G
14 Aug 2026	SCHEDULE 13G/A
11 Aug 2026	S-8
11 Aug 2026	10-Q
11 Aug 2026	8-K: Results of Operations and Financial Condition
17 Jul 2026	SCHEDULE 13D/A
07 Jul 2026	Form 4: Shukla Abhinav A., Chief Technical Officer Received 410 shares by exercise or conversion ($1.46K) · Sold 410 shares ($2.87K) · Received 12,153 shares by exercise or conversion ($43.4K)
02 Jul 2026	Form 4: Shukla Abhinav A., Chief Technical Officer Received 23,365 shares by exercise or conversion ($83.4K) · Sold 23,365 shares ($165K) · Received 100 shares by exercise or conversion ($357) · 1 more
02 Jul 2026	Form 4: Pandite Arundathy N., Chief Medical Officer Sold 30,000 shares ($210K)
02 Jul 2026	144
01 Jul 2026	144
30 Jun 2026	144
17 Jun 2026	SCHEDULE 13G
15 Jun 2026	Form 4: Ashiya Mona, Director Acquired 1,250,000 Pre-Funded Warrants (right to buy) (Open Market Purchase)
15 Jun 2026	Form 4: Orbimed Advisors Llc, Director and 2 others Acquired 1,250,000 Pre-Funded Warrants (right to buy) (Open Market Purchase)
15 Jun 2026	SCHEDULE 13D/A
11 Jun 2026	Form 4: Siegall Clay B, Director Bought 62,500 shares ($250K)
11 Jun 2026	SCHEDULE 13D/A
11 Jun 2026	8-K: Entry into a Material Definitive Agreement
11 Jun 2026	424B5

Comments